FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS

被引：0
|
作者：
Sari, A. [1 ]
Armagan, B. [1 ]
Erden, A. [1 ]
Kilic, L. [1 ]
Karadag, O. [1 ]
Akdogan, A. [1 ]
Bilgen, S. Apras [1 ]
Kiraz, S. [1 ]
Kalyoncu, U. [1 ]
Ertenli, I. [1 ]
机构：
[1] Hacettepe Univ, Sch Med, Rheumatol, Ankara, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4098
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0226
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [41] Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry
    Farisogullari, B.
    Yardimci, G. K.
    Sari, A.
    Bilgin, E.
    Bolek, E. C.
    Duran, E.
    Kilic, L.
    Akdogan, A.
    Karadag, O.
    Bilgen, S. Apras
    Ertenli, A. I.
    Kiraz, S.
    Kalyoncu, U.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (01) : 112 - 119
  • [42] CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTS
    Duran, E.
    Bilgin, E.
    Bolek, E. C.
    Yardimci, G. K.
    Farisogullari, B.
    Kilic, L.
    Akdogan, A.
    Karadag, O.
    Bilgen, S. Arpas
    Kiraz, S.
    Ertenli, A. I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 757 - 757
  • [43] Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results
    Ayan, Gizem
    Farisogullari, Bayram
    Bilgin, Emre
    Bolek, Ertugrul Cagri
    KubraYardimci, Gozde
    Duran, Emine
    Ozsoy, Zehra
    Uzun, Gullu Sandal
    Kilic, Levent
    Akdogan, Ali
    Karadag, Omer
    Bilgen, Sule Apras
    Kiraz, Sedat
    Ertenli, Ali Ihsan
    Kalyoncu, Umut
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1439 - 1446
  • [44] Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results
    Gizem Ayan
    Bayram Farisogulları
    Emre Bilgin
    Ertugrul Cagri Bolek
    Gozde KübraYardımcı
    Emine Duran
    Zehra Ozsoy
    Gullu Sandal Uzun
    Levent Kilic
    Ali Akdoğan
    Omer Karadag
    Şule Apraş Bilgen
    Sedat Kiraz
    Ali İhsan Ertenli
    Umut Kalyoncu
    Clinical Rheumatology, 2022, 41 : 1439 - 1446
  • [45] FATIGUE AND MOOD DISORDERS AS DETERMINANTS OF QUALITY OF LIFE IN PATIENTS WITH RA TREATED WITH BIOLOGICS
    Tanski, W.
    Swiatoniowska-Lonc, N.
    Jankowska-Polanska, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1101 - 1101
  • [46] IMPLICATION OF IDO IN RA PATIENTS TREATED BY BIOLOGICS
    Guillot, X.
    Rulle, S.
    Mussard, J.
    Falgarone, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [47] The risk of malignancies in RA patients treated with biologics
    Askling, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (09): : 774 - +
  • [48] Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
    Seyhoglu, Emrah
    Uyaroglu, Oguz Abdullah
    Erden, Abdulsamet
    Kilic, Levent
    Armagan, Berkan
    Sari, Alper
    Karadag, Omer
    Bilgen, Sule Apras
    Akdogan, Ali
    Ertenli, Ihsan
    Kalyoncu, Umut
    Kiraz, Sedat
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY
    Kiraz, S.
    Kalyoncu, U.
    Karadag, O.
    Kilic, L.
    Akdogan, A.
    Dogan, I.
    Bilgen, S. A.
    Bilgin, E.
    Bolek, E. C.
    Kicasik, B.
    Maras, Y.
    Erden, A.
    Armagan, B.
    Sari, A.
    Duran, E.
    Farisogullari, B.
    Yardimci, G. K.
    Ozsoy, Z.
    Ayan, G.
    Calguneri, M.
    Ertenli, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1124 - 1125
  • [50] QUANTIFERON®-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
    Seyhoglu, E.
    Uyaroglu, O. A.
    Erden, A.
    Kilic, L.
    Armagan, B.
    Sari, A.
    Baykal, M.
    Ak, S.
    Karadag, O.
    Akdogan, A.
    Bilgen, S. Apras
    Kiraz, S.
    Ertenli, I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1412 - 1413
12345